Orion Pharma Limited (DSE: ORIONPHARM)

Market Cap	9.97B
Revenue (ttm)	11.50B
Net Income (ttm)	455.46M
Shares Out	234.00M
EPS (ttm)	1.95
PE Ratio	21.89
Forward PE	n/a
Dividend	1.00 (2.35%)
Ex-Dividend Date	Dec 5, 2024

Volume	1,745,678
Open	43.50
Previous Close	43.30
Day's Range	42.30 - 44.20
52-Week Range	30.90 - 91.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 26, 2024

About Orion Pharma

Orion Pharma Limited engages in the discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. The company produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups like anticancer, antibiotics, anti diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. It also provides various vaccines and health-related consumer products. The company was formerly known as Orion Laboratories Limited and c...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 2,716
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONPHARM

Financial Performance

In 2023, Orion Pharma's revenue was 13.93 billion, an increase of 44.14% compared to the previous year's 9.66 billion. Earnings were 640.94 million, a decrease of -24.25%.